AETHON
Live / Applied — Second extension granted (statement of use) (as of 05 Mar 2026)
What this means for you
Not registered yet, but its 30 May 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98575759
- Mark type
- Design + words
- Filed
- 30 May 2024
- Published for opposition
- 21 Jan 2025
- Attorney of record
- Aaron D. Hendelman
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; antibodies for medical purposes; antibody reagents used for the therapeutic targeting of antigens in cells and tissue for medical purposes; pharmaceutical products for the treatment of cancer
- Class 042 — Scientific and technological services: Scientific research in the field of pharmaceuticals; research and development services in the field of antibodies; medical research services in the field of cancer
Owner
- AETHON THERAPEUTICS, INC., Long Island City, NY, US
- AETHON THERAPEUTICS, INC., New York, NY, US
Prosecution history
- 06 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Mar 2026 — SOU EXTENSION 2 GRANTED
- 05 Mar 2026 — SOU EXTENSION 2 FILED
- 05 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 15 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 09 Sept 2025 — SOU EXTENSION 1 GRANTED
- 09 Sept 2025 — SOU EXTENSION 1 FILED
- 09 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Mar 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 21 Jan 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 21 Jan 2025 — PUBLISHED FOR OPPOSITION
- 15 Jan 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 28 Dec 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 12 Dec 2024 — ASSIGNED TO EXAMINER
- 15 Oct 2024 — NOTICE OF DESIGN SEARCH CODE E-MAILED